Andreas Krebs

Andreas Krebs

Director/Board Member at DEFINIUM THERAPEUTICS, INC.

Net worth: 478 309 $ as of 30/05/2026

67 year
Health Technology
Producer Manufacturing
Miscellaneous

Profile

Andreas R.
Krebs
is Vice Chairman at Definium Therapeutics, Inc. since 2021.
Mr. Krebs is Chairman at Forderverein Girassol.
E.
V.
Mr. Krebs is Trustee at Paul Ehrlich-Foundation.
Mr. Krebs is Trustee at Max-Planck-Institut für molekulare Biomedizin.
Mr. Krebs is Member of the Supervisory Board at Ober Scharrer Gruppe GmbH.
Former roles include Chairman of the Supervisory Board at Merz Beteiligungs GmbH.
From 2012 to 2019, Mr. Krebs was Chairman of the Supervisory Board at Merz Pharma GmbH & Co. KGaA. From 2010 to 2019, Mr. Krebs was Chairman of the Supervisory Board at City of Frankfurt am Main (Germany).
Mr. Krebs was President and Executive Director at Wyeth LLC.
Mr. Krebs was Co-Managing Director at Cologne Invest GmbH.
In 2009, Mr. Krebs was President-Europe, Middle East, Africa and Canada at Wyeth Pharmaceuticals LLC.
From 2011 to 2016, Mr. Krebs was Member of the Supervisory Board at Heidelberg Pharma AG.
Mr. Krebs was Member of the Supervisory Board at SENATOR GmbH.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/06/2026 19,773 ( 0.02% ) 478 309 $ 30/05/2026

Andreas Krebs active positions

CompaniesPositionStart
DEFINIUM THERAPEUTICS, INC. Director/Board Member 28/09/2021
Paul Ehrlich-Foundation
Director/Board Member -
Max-Planck-Institut für molekulare Biomedizin
Director/Board Member -
Director/Board Member -
Forderverein Girassol E V
Chairman -

Former positions of Andreas Krebs

CompaniesPositionEnd
Chairman 30/10/2019
Chairman 31/12/2018
HEIDELBERG PHARMA AG Director/Board Member 12/05/2016
President 30/09/2009
░░░░░ ░░░░░ ░░░░░░░░░ -
See the detail of Andreas Krebs's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

20

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Miscellaneous

Commercial Services

Government

Paul Ehrlich-Foundation

Max-Planck-Institut für molekulare Biomedizin

Health Services

Finance

Health Technology

Forderverein Girassol E V